Newly Funded Research Grants 2025
.png)
Dr. Abhirami Iyer, Washington University School of Medicine
Defining the Role of Microglial Tau in 4R tauopathies.png)
Dr. Seiji Kaji, Kyoto University
Elucidation of Apoe-induced glial cell Tau pathology in PSP.png)
Dr. Yuhao (Harry) Min, Mayo Clinic Jacksonville
Investigating Ddr2 gene downregulation as a novel therapeutic target for PSP and related tauopathies.png)
Dr. Jennifer Rauch, University of Massachusetts Amherst
Development of Novel Models to Understand Tau Seeding in PSP and CBDNewly Funded Research Grants 2024
Dr. Yang You, Mayo Clinic Jacksonville
Characterization of plasma-derived extracellular vesicle proteomics for biomarker development of PSP and CBD.png)
Dr. Peng Zhong, University of Nebraska Medical Center
Mechanisms of Sleep Disturbances in a Mouse Model of Tauopathy.png)
Dr. Steven Boeynaems, Baylor College of Medicine
Dissecting the role of endosomal Toll-like receptors in PSP and CBD
Dr. Kathryn Bowles, University of Edinburgh
Investigating mitochondrial dysfunction as an early pathogenic mechanism of primary tauopathies, using MAPT splicing mutation iPSC-organoids
Dr. Maura Malpetti, University of Cambridge
Blood-based fingerprints of neuroinflammation in people with PSP and CBDNewly Funded Research Grants 2023
Dr. Blas Couto, Institute of Translational and Cognitive Neuroscience (INCyT), Buenos Aires, Argentina
Epidemiology and Tau Biology in a Longitudinal Cohort of Argentinian Patients with PSP and CBD
Dr. Kurt Farrell, Icahan School of Medicine at Mount Sinai, New York, NY
Understanding the Roles of Risk Loci Implicated in Genome-Wide Association Studies of PSP
Dr. Luana Fioriti, Mario Negri Institute for Pharmacological Research, Milan, Italy
Potential Therapeutic Biomarkers for Progressive Supranuclear PalsyOngoing Funded Grants
Join our email list
Get the latest news and resources
directly to your inbox.
Get the latest news and resources directly to your inbox.
Sign Up